U.S. regulators said Friday that they have authorized the emergency use of the experimental anti-viral drug remdesivir for treating coronavirus patients, saying that clinical trials have showed "promising results.""While there is limited information known about the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19, the investigational drug was shown in a clinical trial to shorten the time to recovery in some patients," the U.S. Food and Drug Administration said in a statement.The move, which will enable the drug to be used for those hospitalized with…READ FULL ARTICLE